✦ LIBER ✦

Assessment of Atherothrombosis and Its Treatment in Mexico: First-Year Data of the REACH Registry

✍ Scribed by Efraín Gaxiola; Luis Eng-Ceceña; Fernando Ortiz-Galván; Leonardo Llamas-López; Ricardo Rangel-Guerra; Marco A. Alcocer-Gamba; Deepak L. Bhatt; P. Gabriel Steg;; the REACH Registry Investigators

Book ID: 112061253
Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 559 KB
Volume: 33
Category: Article
ISSN: 0160-9289
DOI: 10.1002/clc.20800

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cardiovascular risk profile and outcome

Cardiovascular risk profile and outcome of patients with abdominal aortic aneurysm in out-patients with atherothrombosis: Data from the Reduction of Atherothrombosis for Continued Health (REACH) Registry

✍ Iris Baumgartner; Alan T. Hirsch; Maria Teresa B. Abola; Patrice P. Cacoub; Don 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 173 KB

Ethnic differences in the prevalence and

Ethnic differences in the prevalence and treatment of cardiovascular risk factors in US outpatients with peripheral arterial disease: Insights from the Reduction of Atherothrombosis for Continued Health (REACH) Registry

✍ Telly A. Meadows; Deepak L. Bhatt; Alan T. Hirsch; Mark A. Creager; Robert M. Ca 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 229 KB

Abatacept and its use in the treatment o

Abatacept and its use in the treatment of rheumatoid arthritis (RA) in the Czech Republic—data from the ATTRA registry

✍ Horák, Pavel; Skácelová, Martina; Hejduk, Karel; Smržová, Andrea; Pavelka, Karel 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 237 KB

Incidence and prevalence rate estimation

Incidence and prevalence rate estimation of GH treatment exposure in Piedmont pediatric population in the years 2002–2004: Data from the GH Registry

✍ Migliaretti, G.; Aimaretti, G.; Borraccino, A.; Bellone, J.; Vannelli, S.; Angel 📂 Article 📅 2006 🏛 Springer-Verlag 🌐 English ⚖ 108 KB

ATRIAL FIBRILLATION TREATMENT PARADOX: C

ATRIAL FIBRILLATION TREATMENT PARADOX: CHARACTERISTICS OF AND FIRST-YEAR EVENTS IN PATIENTS NOT TREATED WITH VITAMIN-K ANTAGONISTS COMPARED TO TREATED PATIENTS. THE GARFIELD REGISTRY

✍ Bassand, Jean-Pierre L.; Rushton-Smith, Sophie; Camm, A John; Goldhaber, Samuel 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 149 KB

THE GLOBAL REGISTRY PROGRAM ON LONG-TERM

THE GLOBAL REGISTRY PROGRAM ON LONG-TERM ORAL ANTI-THROMBOTIC TREATMENT IN PATIENTS WITH ATRIAL FIBRILLATION (GLORIA-AF): FIRST ASSESSMENT OF BASELINE CHARACTERISTICS OF DABIGATRAN AND VKA COHORTS IN NORTH AMERICA

✍ Rothman, Ken; Huisman, Menno V.; Lip, Gregory; Diener, Hans-Christoph; Dubner, S 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 237 KB